Validation of the MSKCC and Heng Risk Criteria Models for Predicting Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib
2013; Springer Science+Business Media; Volume: 20; Issue: 13 Linguagem: Inglês
10.1245/s10434-013-3290-1
ISSN1534-4681
AutoresWhi‐An Kwon, In‐Chang Cho, Ami Yu, Byung‐Ho Nam, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung,
Tópico(s)Multiple and Secondary Primary Cancers
Referência(s)